Antibody Persistence and Response to Re-vaccination With Either Menactra® or Menomune® 3 Years After Initial Vaccination

Clinical trial NCT01239043 · COMPLETED

Trial details

NCT number: NCT01239043
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Meningitis Meningococcal Meningitis Meningococcal Infections

Start date: 2010-11-01
Primary completion: 2011-04-01
Enrollment: 139

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.